Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-08 15:28:05 - browse：784

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Male and female sex labels in research insufficient, scientists say

hotspot

WSS

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

How to save health care price transparency rules

Immunocompromised patients offer clues on chronic Covid

Head of FDA's diagnostics center, who led through Covid, retires

HHS secretary Becerra pressed on Change HealthCare cyberattack

Medicare coverage of Wegovy, once blocked, now looks possible

explore

Wikipedia

focus

Drug repurposing or repositioning? The language matters

EPA limits use of carcinogenic gas for sterilizing medical devices

Hepatitis C has a cure — but many Americans still lack access to it

TikTok, Instagram influencers need more rules for drug ads

In Memoriam: Notable people who died in 2023

Cardiologists urge adding sexual orientation, gender identity to health records

BioMarin wins approval for gene therapy to treat hemophilia A

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Cancer drug shortages should be causing more outrage

Dana Farber says 6 studies to be retracted and 31 corrected

entertainment

The inclusion problem at the heart of rehabilitation research

How many hemophilia patients actually want gene therapy?

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

A pediatrician calls for Congress to pass the child tax credit deal

Immunocompromised patients offer clues on chronic Covid

As AI in medicine takes off, can 'human in the loop' prevent harm?

knowledge

hotspot

Wikipedia

entertainment